Premium
Commentary: assessing remission in coeliac disease – are deamidated gliadin peptide antibodies the answer?
Author(s) -
Mooney P. D.,
Sanders D. S.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12638
Subject(s) - tissue transglutaminase , medicine , coeliac disease , villous atrophy , gliadin , antibody , biopsy , serology , immunology , disease , gastroenterology , gluten , pathology , biology , biochemistry , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom